ASH: CAR T-Cell Therapy Promising for Relapsed/Refractory iNHL
WEDNESDAY, Dec. 9, 2020 — Axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor T-cell therapy, is promising for the […]
iNHL
WEDNESDAY, Dec. 9, 2020 — Axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor T-cell therapy, is promising for the […]iNHL
ASH: CAR T-Cell Therapy Promising for Relapsed/Refractory iNHL
Copyright © 2025